Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oculomotor and Cognitive Examination in ADHD Management
NCT03411434Unknown
- Sponsor
- Centre Hospitalier de Rouffach
- Start
- Feb 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Centre Hospitalier de Rouffach. Primary endpoints: Change in saccade latency, Change in saccade average speed and 4 more. Status: unknown.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03411434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03411434.